Medical Hypotheses
Volume 55, Issue 6 , Pages 470-473 , December 2000

Tissue factor expression and multidrug resistance in cancer: two aspects of a common cellular response to a hostile milieu

  • B.A. Lwaleed

      Affiliations

    • MDR Research Group, Departments of Urology/Surgery, Southampton University Hospitals, Southampton, UK
    • ,
  • A.J. Cooper

      Affiliations

    • Department of Pharmacy and Biomedical Science, University of Portsmouth, UK

Received 10 November 1999 ,Accepted 16 February 2000.

References 

    REFERENCES
  1. Nemerson Y, Bach R. Tissue factor revisited. Hemost Thromb. 1982;6:237–261
  2. Nemerson Y. The tissue factor pathway of blood coagulation. Semin Haemost. 1992;29:170–176
  3. Magdolen V, Albrecht S, Kotzsch M. Immunological and functional analyses of the extracellular domain of human tissue factor. Biol Chem. 1998;379:157–165
  4. Carty N, Taylor I, Roath O, El-Baruni K, Francis J. Urinary tissue factor activity in malignancy. Thromb Res. 1990;57:473–478
  5. Lwaleed BA, Chisholm M, Francis JL. The significance of measuring monocyte tissue factor levels in patients breast and colorectal cancer. Br J Cancer. 1999;80:279–285
  6. Carmeliet P, Collen D. Molecules in focus: Tissue Factor. Int J Biochem Cell Biol. 1998;30:661–667
  7. Fischer EG, Ruf W, Muller BM. Tissue factor-initiated thrombin generation activates the signalling thrombin receptor on malignant melanoma cells. Cancer Res. 1995;5:1629–1632
  8. Carmeliet P, Mackman N, Moons L. Role of tissue factor in embryonic blood vessel development. Nature. 1996;383:73–75
  9. Kwaan HC. The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev. 1994;11:291–311
  10. Honn KV, Tang DG, Crissman JD. Platelets and cancer metastasis: a causal relationship?. Cancer Metastasis Rev. 1992;11:325–351
  11. Contrino J, Hair G, Kreutzer D, Rickles F. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nature Med. 1996;2:209–215
  12. Folkman J. Tumour angiogenesis and tissue factor. Nature Med. 1996;2:167–168
  13. Toomey J, Kratzer K, Lasky N, Broze G. Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci USA. 1997;94:6922–6926
  14. Gerlach J, Endicott J, Juranka P. Homology between P-glycoprotein and a bacterial hemolysin transport protein suggests a model for multidrug resistance. Nature. 1986;324:485–489
  15. Fidler IJ. Modulation of the organ micro-environment for treatment of cancer metastases. J Natl Cancer Inst. 1995;87:1588–1592
  16. Clifford SC, Neal D. E, Lunec J. High level expression of the multidrug resistance (MDR1) gene in the normal bladder urothelium: a potential involvement in protection against carcinogens. 1996;17:601–604
  17. Kessel D, Dodd DC, Hall TC. Some determinants of drug responsiveness in bovine leukemia cells. Biochem Pharmacol. 1973;22:1161–1164
  18. Eytan GD, Regev R, Oren G, Assaraf YG. The role of passive transbilayer drug movement in multidrug resistance and its modulation. J Bio Chem. 1996;271:12897–12902
  19. Sharom FJ. The P-glycoprotein efflux pump: how does it transport drugs?. J Membr Biol. 1997;160:161–175
  20. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood. 1983;62:14–31
  21. Tallman MS, Hakimian D, Kwaan HC, Rickles FR. New insight into pathogenesis of coagulation dysfunction in acute promyelocytic leukemia. Leuk Lymphoma. 1993;11:27–36
  22. Hair GA, Padula S, Zeff R. Tissue factor expression in human leukaemic cells. Leuk Res. 1996;20:1–11
  23. Weiss RB, Tormey DC, Holland JF, Weinberg VE. Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Repo. 1981;65:677–679
  24. Calsen E, Prydz H. Enhancement of procoagulant activity in stimulated mononuclear blood cells and monocytes by cyclosporin. Transplantation. 1987;43:453–548
  25. Walsh J, Wheeler HR, Carolyn L. Modulation of tissue factor on human monocytes by cisplatin and adriamycin. Br J Haematol. 1992;81:480–488
  26. Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol. 1996;3:379–384
  27. Hu T, Bach R, Horton R, Konigsberg W, Todd M. Synthesis of tissue factor messenger RNA and procoagulant activity in breast cancer cells in response to serum stimulation. Thromb Res. 1993;72:155–168
  28. Fine RL, Patel J, Chabner BA. Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA. 1988;85:582–586
  29. Fenton J, Rumsby MG, Warr JR. The relationship between protein kinase C and multidrug resistance in chinese hamster ovary cells (Abstract). Cytotechnology. 1996;19:264
  30. Crossman DC, Carr DP, Tuddenham EGD, Pearson JD, McVey JH. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem. 1990;265:9782–9787
  31. Scarpati EM, Sadler JE. Regulation of endothelial cells coagulant activity. J Biol Chem. 1989;264:20705–20713
  32. Satta N, Toti F, Feugeas O. Monocytes Vesiculation. A mechanism for dissemination of membrane-associated procoagulant activity and adhesion molecules after stimulation by LPS. J Immunol. 1994;153:3245–3255
  33. Hayes M, Duffy P, Cooper A, Smart C. Membrane charge and phospholipid asymmetry in multidrug resistance (Abstract). Cytotechnology. 1996;19:287
  34. Greeno E, Bach R, Moldow C. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest. 1996;75:281–289
  35. Lwaleed BA, Bass PS, Francis JL, Chisholm M. Functional and structural properties of urinary tissue factor. Nephrol Dial Transplant. 1999;14:588–596
  36. Thiebaut F, Tsuruo T, Hamada H, Gottesman M, Pastan I, Willingham MC. Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA. 1987;84:7735–7738
  37. Gately S, Twardowski P, Stack M. The mechanism of cancer mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci USA. 1997;94:10868–10872
  38. Lwaleed BA, Chisholm M, Francis JL. Urinary tissue factor level in patients with breast and colorectal cancer. J Pathol. 1999;187:291–294
  39. Wiggins R, Glatfelter A, Kshirsagar B, Beals T. Lipid microvesicles and their association with procoagulant activity in urine and glomeruli of rabbits with nephrotoxic nephritis. Lab Invest. 1987;56:264–271
  40. Lwaleed BA, Chisholm M, Francis JL. Development and validation of an assay for urinary tissue factor activity. J Clin Pathol. 1999;52:219–224

PII: S0306-9877(00)91093-4

doi: 10.1054/mehy.2000.1093

Medical Hypotheses
Volume 55, Issue 6 , Pages 470-473 , December 2000

Article Tools